Geloca, Lilibeth T.
HRN: 29-27-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2026
CEFTRIAXONE 1G (VIAL)
07/10/2026
07/16/2026
IV
2G
OD
CAP MR
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines